# Liquid Biopsy

> [**PDFs**](https://cloud.tsinghua.edu.cn/d/07d2b19d6b284ebea5ea/?p=%2F1.%20Precision%20Medicine\&mode=list)
>
> ✅ or ✨ **: recommended readings**

> **关于液体活检技术的科普:**
>
> * **News**
>   * 2022 Nature - GRAIL and the quest for earlier multi-cancer detection
>   * 2022 - 肿瘤早筛，群雄谁能逐鹿？([Wechat link](https://mp.weixin.qq.com/s/qbjdqVSZqWsjE0jR4bzFtQ) | [Everhub link](https://www.yinxiang.com/everhub/note/86e90ab1-550a-40bf-923e-5e1b68be4b98))&#x20;
>   * 2022 - New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening ([_Cancer Cell_ Commentary](https://www.sciencedirect.com/science/article/pii/S1535610822000149?via%3Dihub))
>   * 2022 - Omics and AI advance biomarker discovery for liver disease ([_Nature Medicine_ News](https://www.nature.com/articles/s41591-022-01853-9))
>   * 2019 - 为何投资者对癌症ctDNA液体活检依旧“信心满满，热情高涨” - NBT解析背后原因 ( [Wechat link](https://mp.weixin.qq.com/s/XbXB8cpw1uMQMId7uIirfA) | [Nature Biotech.](https://www.nature.com/articles/d41587-019-00022-7) )
>   * 2019 - 开启肿瘤早筛新纪元，液态活检蓄势待发 ( [Everhub link](https://www.yinxiang.com/everhub/note/d1062a1d-14a8-4e8c-af9b-70aa808715da); [Wechat link](https://mp.weixin.qq.com/s/I_mlH_l4ORrAZS_rv9bytQ) )
> * **Patents**&#x20;
>   * 2019 - Nature Biotech. - Recent patents in cancer detection&#x20;
> * [Collections](https://www.cell.com/consortium/exRNA) of exRNA Consortium (ERCC) @ _Cell_
> * [Outlook collection](https://www.nature.com/collections/hibdgeeijf) of _Nature_ ([Could tracking RNA in body fluids reveal disease?](https://www.nature.com/articles/d41586-020-01763-1) )



## 0. Representative Publications

### cfDNA - cancer

* **2024 Nature Communications** - Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology
* **2024 Science Translational Medicine** - Genome-wide repeat landscapes in cancer and cell-free DNA
* **2024 The New England Journal of Medicine** -  A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening
* **2023 Nature Medicine** - Liquid biopsy epigenomic profiling for cancer subtyping
* **2023 Nature Genetics** - Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer
* **2023 Science Translational Med.** - Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
* **2023 Cancer Discovery** - Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA
* **2022 Cancer Cell** - Evaluation of cell-free DNA approaches for multi- cancer early detection
* **2020 Nature** - Integrating genomic features for noninvasive early lung cancer detection
* **2020 Nature** - Microbiome analyses of blood and tissues suggest cancer diagnostic approach
* **2020 Science** - Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
* **2019 Nature** - Genome-wide cell-free DNA fragmentation in patients with cancer
* **2018 Nature** - Sensitive tumour detection and classification using plasma cell-free DNA methylomes
* **2018 Science** - Detection and localization of surgically resectable cancers with a multi-analyte blood test

### cfRNA - cancer

* [**2025 Nature** ](https://www.nature.com/articles/s41586-025-08834-1)_-_ An ultrasensitive method for detection of cell-free RNA
* **2025 Genome Biology** - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential.&#x20;
* **2023 Nature BME** - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer
* **2022 Cancer Cell** - Detection and localization of early- and late-stage cancers using platelet RNA
* **2022 eLife** - Cancer type classification using plasma cell-free RNAs derived from human and microbes
* **2018 Nature Med.** - Cancer cells exploit an orphan RNA to drive metastatic progression

### cfRNA - pregnancy

* **2022 Nature** - Early prediction of preeclampsia in pregnancy with cell-free RNA
* **2022 Nature** - RNA profiles reveal signatures of future health and disease in pregnancy
* **2022 Nature Biotech.** - Cell types of origin of the cell-free transcriptome
* **2020 Science Translational Med.** - Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia
* **2018 Science** - Noninvasive blood tests for fetal development predict gestational age and preterm delivery



## I. Reviews of Liquid Biopsy

* 2022 Nature Reviews - Circulating tumour DNA — looking beyond the blood
* 2022 Science - Early Detection of Cancer
* ✨ 2022 Nature Biomedical Engineering - Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics
* 2021Mol. Cancer - The role and application of small **extracellular vesicles** in gastric cancer
* ✨ 2021 Science - Epigenetics, fragmentomics, and topology of **cell-free DNA** in liquid biopsies
* ✨ 2020 Nature - Outlook - Putting **extracellular RNA** to the diagnostic test
* 2020 Nature Reviews - **RNA** delivery by **extracellular vesicles** in mammalian cells and its applications
* 2020 Science - The biology, function, and biomedical applications of **exosomes**
* ✨ 2020 Genome Biology - The promise and challenge of cancer **microbiome** research
* 2019 Cell - Review - The Role of **Non-coding RNAs** in Oncology
* ✨ 2018 Nature Reviews | clinica l oncology - Clinical utility of **circulating non-coding RNAs** — an update
* ✨ 2018 Nature Reviews | Genetics - Current and future perspectives of **liquid biopsies** in **genomics**-driven oncology
* 2018 Nature Reviews | Clin Oncol. - Extracellular vesicles in cancer - implications for future improvements in cancer care
* 2018 NEJM - Circulating Extracellular Vesicles in Human Disease ([翻译版](https://www.nejmqianyan.cn/article/YXQYra1704286))
* 2018 NEJM - Application of **Cell-free DNA** Analysis to Cancer Treatment ([翻译版](https://www.nejmqianyan.cn/article/YXQYra1706174))
* 2018 NEJM - Sequencing of circulating cell-free dna during **pregnancy** ([翻译版](https://www.nejmqianyan.cn/article/YXQYra1705345))

> **Comparison of different liquid biopsy tech. :** [**Comparison Table**](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/files/?p=/liquid%20biopsy%20tech%20comparison.pptx)

## II. cfDNA

* **Multianalyte & Multiomics**&#x20;
  * **2024 Cell Reports Medicine** - Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis
  * ✅ **cfDNA+cfDNAmet+cfRNA-S+cfRNA-L** - [**2023&#x20;**_**Cell Reports Medicine**_ ](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791\(23\)00475-5)- Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood
  * ✅ **cfDNA+cfDNAmet** - [**2023 Cancer Discovery**](https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-23-0456/729598/Early-Cancer-Detection-in-Li-Fraumeni-Syndrome) - Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA&#x20;
  * **cf-WGS+cf-WGBS - 2022&#x20;**_**Cancer Cell**_ - Evaluation of cell-free DNA approaches for multi- cancer early detection
  * **CancerSEEK+PET-CT:&#x20;**_**2020 Science -**_ Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
  * ✅ **\~60 cfDNA + 8 proteins (CancerSEEK):&#x20;**_**2018 Science**_ - Detection and localization of surgically resectable cancers with a multi-analyte blood test
* **cfDNA/mbDNA** &#x20;
  * **2024 Science Translational Medicine** - Machine learning to detect the SINEs of cancer
  * **2023 GB** - The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection
  * **2023 Nature Genetics** - Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer
  * **2023 STM** - Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
  * &#x20;✅ \[**end-motif]** **2023 PNAS** - Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs
  * **2022 Cancer Discovery** - Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes
  * **cfDNA SNV+met**: [_**2022 Science Trans. Med.**_ ](https://www.science.org/doi/10.1126/scitranslmed.abp8704)- Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
  * **Captured ctDNA SNV+CNV:&#x20;**_**2020 Nature**_ - Integrating genomic features for noninvasive early lung cancer detection
  * **Microbiome:&#x20;**_**2020 Nature**_ - Microbiome analyses of blood and tissues suggest cancer diagnostic approach&#x20;
  * **Fragmentome (DELFI):** [_**2022 Cancer Discovery**_](https://www.science.org/doi/10.1126/scitranslmed.abp8704) **-** Detecting liver cancer using cell-free DNA fragmentomes
  * **Fragmentome (DELFI): 2021 Nature Commn.** - Detection and characterization of lung cancer using cell-free DNA fragmentomes
  * ✅ **Fragmentome (DELFI):&#x20;**_**2019 Nature**_ - Genome-wide cell-free DNA fragmentation in patients with cancer
* **cfDNA Methylation**&#x20;
  * ✅ \[Grail, cfDNA vs. cfDNAmet] - [**2022 Cancer Cell** ](https://doi.org/10.1016/j.ccell.2022.10.022)- Evaluation of cell-free DNA approaches for multicancer early detection
  * \[Grail, Targeted BS] _**2022 ESMO congress**_ - PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test
  * \[Grail, Targeted BS] [_**2021 Annals of Oncology**_](https://www.science.org/doi/10.1126/scitranslmed.abp8704) **-** Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
  * \[Grail, Targeted BS] _**2020 Annals of Oncology**_**&#x20;-** Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
  * ✨ \[meDIP] _**2018 Nature**_ - Sensitive tumour detection and classification using plasma cell-free DNA methylomes
* **cfDNAmet and histone modification**
  * [**2023 Nature Medicine** ](https://www.nature.com/articles/s41591-023-02605-z)**-** Liquid biopsy epigenomic profiling for cancer subtyping
  * **2021 Nature Biotech.** - ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin



## III. cfRNA (exRNA)&#x20;

> **cfRNA** (cell-free RNA) is also called **exRNA** (extracellular RNA)

### **Pregnancy**

*   (**ccfDNA - 2023&#x20;**_**Lancet**_ Cell-free fetal DNA for genetic evaluation in Copenhagen

    Pregnancy Loss Study (COPL): a prospective cohort study)
* ✅ **long cfRNA-seq**: _**2022 Nature**_  Early prediction of preeclampsia in pregnancy with cell-free RNA
* **Captured long cfRNA-seq**: _**2022 Nature**_ RNA profiles reveal signatures of future health and disease in pregnancy
* **2020 Science translational medicine** - Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia
* ✅ **Long cfRNA-seq**: _**2018 Science**_ - Noninvasive blood tests for fetal development predict gestational age and preterm delivery
* **long cfRNA-seq**: _**2017 Clinical chemistry**_ - Simultaneously Monitoring Immune Response and Microbial Infections during Pregnancy through Plasma cfRNA Sequencing

### Cancer

* **Long**
  * ✅ **Captured long cfRNA-seq:** [**2025&#x20;**_**Nature**_ ](https://www.nature.com/articles/s41586-025-08834-1)_-_ An ultrasensitive method for detection of cell-free RNA
  * ✅ **cfDNA+cfDNAmet+cfRNA-S+cfRNA-L** - [**2023&#x20;**_**Cell Reports Medicine**_ ](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791\(23\)00475-5)- Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood
  * **2023 Nature biomedical engineering** - Nature Profiling of repetitive RNA sequences in the blood plasma of patients with cancer
  * **2023 Nature Commn.** - Terminal modiﬁcations independent cell-free RNA sequencing enables sensitive early cancer detection and classiﬁcation
  * _**2022 NPJ precision oncology**_ - Plasma cell-free RNA proﬁling distinguishes cancers from premalignant conditions in solid and hematologic malignancies
  * _**2021 Clinical Chem.**_ - Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma
  * **long cfRNA-mRNA:&#x20;**_**2021 Nature Commn.**_**&#x20;- Grail** - A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
  * **long evRNA-mRNA:&#x20;**_**2021 Mol Cancer**_ - Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer&#x20;
  * **long cfRNA-ncRNA** _-_ **2021&#x20;**_**Theranostics**_ _-_ Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer
  * **✨ long evRNA-seq**: _**2020 GUT**_ Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
  * **mRNA/lncRNA fragments**: _**2019 EMBO J.**_  - Phospho‐RNA‐seq: a modified small RNA‐seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma
  * **SILVER-seq**: _**2019 PNAS**_ - Extracellular RNA in a single droplet of human serum reflects physiologic and disease states
  * **long evRNA-seq**: _**2019 Clinical Chemistry**_ - Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis
  * **exoRBase:** _**2018 NAR**_ - exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes
  * **2018 PNAS** - Human plasma and serum extracellular small RNA reference profiles and their clinical utility
  * **exRNA Components**: _**2017 Nature Communication**_ - Coding and noncoding landscape of extracellular RNA
  * **Prospective Review**: _**2017 Noncoding RNA**_ - RNA Biomarkers: Frontier of Precision Medicine for Cancer
* **Long - Platelet**&#x20;
  * ✅ **Platelet RNA:** [**2022 Cancer Cell**](https://doi.org/10.1016/j.ccell.2022.08.006) - Detection and localization of early- and late-stage cancers using platelet RNA
  * _**2022 Genome Medicine**_ - RNA profiling of blood platelets noninvasively differentiates colorectal cancer from healthy donors and noncancerous intestinal diseases: a retrospective cohort study
  * **Platelet RNA:** _**2015 Cancer Cell**_ - RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
  * **Platelet RNA:** _**2017 Cancer Cell**_ - Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
* **Small/Frag.**
  * ✨ **2025&#x20;**_**Genome Biology**_ - Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential.&#x20;
  * ✨ **oncRNA: 2024 bioRxiv** - Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers
  * **unannotated exRNAs**: _**2021 GUT -**_ Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer
  * **small exosomal RNA:** _**2019 Molecular Cancer**_ - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
  * **small cfRNA**: _**2015 Scientific Report**_ - Plasma extracellular RNA profiles in healthy and cancer patients
  * **structured ncRNA domain (small cfRNA-seq)**: _**2019 Clinical chemistry**_  - Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma
  * ✨ **oncRNA:** _**2018 Nature Med.**_ - Cancer cells exploit an orphan RNA to drive metastatic progression
  * **miRNA7**: _**2011 JCO**_ - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma

### Infectious Diseases

* [**2024 Nature Communications**](https://doi.org/10.1038/s41467-024-49245-6) - Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis
* [**2022 Genome Res.**](https://genome.cshlp.org/content/32/2/228) - Plasma cell-free RNA characteristics in COVID-19 patients

### **Neural Diseases**

* **small cfRNA -&#x20;**_**2021 PNAS**_ -  - Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology
* **long cfRNA-mRNA**: _**2020 Science Advance**_ - Noninvasive characterization of **Alzheimer’s disease** by circulating cell-free messenger RNA next-generation sequencing
* **cfRNA**: _**2020 Current Biology**_ - Presymptomatic increase of an extracellular RNA in blood plasma is associated with the development of Alzheimer’s disease

### **ERCC**  (_**2019 Cell papers**_)

* **exceRpt**: Cell system 2019 - exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling
* **Extracellular carriers**: Cell minireview 2019 - Mapping Extracellular RNA Sheds Lights on Distinct Carriers
* **ERCC perspective**: Cell perspective 2019 - The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research
* **Exosome preview**: Cell preview 2019 - Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication
* **✨ Exosome composition**: Cell article 2019 - Reassessment of Exosome Composition
* **exRNA carriers**: Cell resource 2019 - exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids
* **Small exRNA-seq**: Cell resource 2019 - Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation
* **Exosome PD-L1**: Cell article 2019 - Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory



## IV. Others - Proteome etc

### **TCR**

* **2020** - _**Science Transl. Med.**_ - De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection

### **Proteome**

* ✅ \[Plasma proteome] [**2023&#x20;**_**Nature**_ ](https://www.nature.com/articles/s41586-023-06802-1)**-** Organ aging signatures in the plasma proteome track health and disease
* \[Plasma proteome] _**2022 Nature Medicine**_ - Noninvasive proteomic biomarkers for alcohol-related liver disease
* ✅  \[MS-EVP] **Exosomic proteins**: _**2020 Cell**_ - Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
* \[APPA] _**2020 Sci Adv** -_ Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response

### Metabolome

* **2024 Nature Commn.** - Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer

